Re:US appeals court rules in favor of patenting genes
by anigbrowl on Thursday August 23, 2012 @05:21PM
(#4424922)
It's easy now; I don't think it was all that easy back in 1994 when they first sequenced BRCA-1 or when they first began work on it back around 1988.
[ Parent
| on HN ]
Re:US appeals court rules in favor of patenting genes
by thronemonkey on Thursday August 23, 2012 @08:13PM
(#4425587)
It was easy even then. PCR and Sanger sequencing have been in wide use for a long time. Yes, Myriad did do a lot of streamlining and optimizing, but everything they did was with preexisting technologies. There's nothing novel or innovative at all—they developed a very efficient analysis pipeline, but that's not something anyone should ever be awarded a patent for.
Re:US appeals court rules in favor of patenting genes
by anigbrowl on Thursday August 23, 2012 @10:22PM
(#4425917)
In that case, why haven't their legal antagonists built their case around a straightforward prior art argument, instead of amking normative arguments about the patentability of human DNA?
Re:US appeals court rules in favor of patenting genes
by thronemonkey on Friday August 24, 2012 @05:45PM
(#4429845)
Not sure, might have something to do with the ACLU/AMP wanting to set a wide reaching precedent that patents of endogenous DNA sequences are not ok? They won't just want to win the single case, they want to change the wider legal landscape concerning patents and biological science.
Re:US appeals court rules in favor of patenting genes
by WildUtah on Thursday August 23, 2012 @08:09PM
(#4425573)
I did it in an undergrad lab class in 1994. It took some fancy equipment, target data from published reports on particular sequences, appropriate cells, salts, and enzymes. And it took me about 25 lab hours to get it right.
But it wasn't hard. An undergrad could do it.
Maybe not in 1988, though. I was in junior high then.